DOXACURIUM CHLORIDE: A PRELIMINARY CLINICAL TRIAL

Open Access
Publisher Website
Google Scholar
Abstract
The onset, duration of action and reversibility of doxacurium were studied in 27 anaesthetized patients, using doses of 37.5 μg kg−1 (1.5×ED95) and 62.5 μg kg−1 (2.5×ED95). Onset was slow and, whilst tracheal intubation was always possible 3 or 4 min after injection, the conditions were not ideal. With the higher dose a mean 97.6 (SD 5.2)% block of the response of adductor pollicis to ulnar nerve stimulation was obtained in 9.85 (6.17) min and recovery of the integrated EMG response to 20% of control took 102 min (42 min). After these initial doses, when incremental doses were given there was no sign of cumulation of effect. Antagonism of block with edrophonium 1 mg kg−1, whilst fast in onset, was rarely complete; with neostigmine 50 μg kg−1 antagonism was satisfactory. No adverse haemodynamic effect was seen, although a gradual onset of bradycardia, which responded to atropine or glycopyrrolate, was noted in 12 of the patients. No histamine release or other adverse effects were noted.

This publication has 1 reference indexed in Scilit: